What happens beyond diabetes?

What happens beyond diabetes?

Looking at the results released by Abbott this morning and listening to call that accompanied the results the key question we have is what happens beyond diabetes. As we have said for some time now CGM is now the standard for glucose measurement. This is not to say there is no room for growth in the diabetes segment rather growth in diabetes at this point will be more methodical. As Abbott CEO Robert Ford noted today there are still sub-segments in the diabetes market where CGM remains under penetrated but the days of this segment growing at 20 . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.